CBLL

Ceribell, Inc.

Nasdaq · Electromedical & Electrotherapeutic Apparatus · Inc. DE · CIK 0001861107

$18.08 -0.08% $686.8M

Insider Selling Cluster (2 insiders)High Impact Filing (8/10)3 New Institutional Positions

Vol

Market Cap$686.8M

Cap SizeSmall Cap

Analyst ConsensusStrong Buy (93%)

Inst. Holders7 funds

Inst. Value$142.3M

Inst. Activity3 buys / 0 sells

Insider Activity0B / 16S

Insider Net $-$1.7M

SEC Reports12

Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001861107·Prev Close $18.10

Recent Activity

May 20, 2026 other

Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference

<p>SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”),

May 11, 2026 SEC

Ceribell reported Q1 2026 revenue of $26.5M (+29% YoY), beating the $26.1M consensus, and EPS of -$0.52 (GAAP) vs consen

PRESS-RELEASE — Impact 6/10

May 7, 2026 SEC

Insider cluster at Ceribill showing two sells by CEO and CTO totaling ~$312K, which is only 0.04% of market cap. Derivat

CLUSTER — Impact 2/10

May 5, 2026 Insider

Chao Xingjuan sold 1,446 shares

President and CEO @ $0.00 ($0.00)

May 5, 2026 Insider

Chao Xingjuan sold 1,446 shares

President and CEO @ $4.70 ($6.8K)

May 5, 2026 Insider

Chao Xingjuan sold 14,000 shares

President and CEO @ $20.12 ($281.7K)

Apr 20, 2026 SEC

Ceribell issued a press release announcing the upcoming release of its Q1 2026 financial results, with no actual financi

PRESS-RELEASE — Impact 3/10

Inst.

BANK OF AMERICA CORP — DOUBLED

277,497 shares ($6.1M)

Price Targets

$26.86 +48.5% upside Strong Buy

Current $18.09 Low $24.00 Median $26.00 High $32.00 7 analysts

$24.00 $32.00

Analyst Ratings

Strong Buy93% buy · 14 analysts

7Strong Buy

6Buy

1Hold

0Sell

0Strong Sell

Recent Analyst Actions

Date	Firm	Action	Rating
May 12, 2026	Canaccord Genuity	MAINTAIN	Buy → Buy
Jan 28, 2026	BTIG	REITERATE	Buy → Buy
Dec 17, 2025	Canaccord Genuity	MAINTAIN	Buy → Buy
Dec 15, 2025	BTIG	REITERATE	Buy → Buy

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$-0.46 ▼ -17.6%	$-0.50 — $-0.36	-21% YoY	4
Next Q	$-0.37 ▼ -5.6%	$-0.38 — $-0.34	-0% YoY	4
Current FY	$-1.68 ▼ -15.5%	$-1.74 — $-1.55	-15% YoY	4
Next FY	$-1.10 ▼ -9.2%	$-1.30 — $-0.91	35% YoY	5

Latest Reports

MIXED PRESS-RELEASE 6/10

Ceribell reported Q1 2026 revenue of $26.5M (+29% YoY), beating the $26.1M consensus, and EPS of -$0.52 (GAAP) vs consen

May 11, 2026

NEUTRAL CLUSTER 2/10

Insider cluster at Ceribill showing two sells by CEO and CTO totaling ~$312K, which is only 0.04% of market cap. Derivat

May 7, 2026

Top Institutional Holders

Fund	Value	Move
FMR LLC	$86.2M	—
VANGUARD GROUP INC	$33.1M	ADD
TWO SIGMA INVESTMENTS, LP	$7.5M	ADD
BANK OF AMERICA CORP	$6.1M	DOUBLED
MORGAN STANLEY	$4.6M	ADD

Recent Insider Trades

Date	Insider	Type	Value
May 5, 2026	Chao Xingjuan	M	$0.00
May 5, 2026	Chao Xingjuan	M	$6.8K
May 5, 2026	Chao Xingjuan	SELL	$281.7K
May 1, 2026	Woo Raymond	M	$3.3K
May 1, 2026	Woo Raymond	SELL	$30.0K

7 institutional holders with $142.3M total value (6,487,296 shares) as of 2025-Q4. Top holders: FMR, VANGUARD, TWO. Net buying activity: 3 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#	Fund	Shares	Value	% of Tracked	Last Move
1	FMR LLC	3,928,666	$86.2M	60.6%	—
2	VANGUARD GROUP INC	1,507,909	$33.1M	23.2%	ADD +90.0%
3	TWO SIGMA INVESTMENTS, LP	343,640	$7.5M	5.3%	ADD +81.0%
4	BANK OF AMERICA CORP /DE/	277,497	$6.1M	4.3%	DOUBLED +104.4%
5	MORGAN STANLEY	209,668	$4.6M	3.2%	ADD +35.7%
6	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	190,561	$4.2M	2.9%	ADD +26.6%
7	WELLS FARGO & COMPANY/MN	29,355	$643.8K	0.5%	ADD +89.3%

Recent Position Changes

Fund	Action	Prev Shares	Curr Shares	Change %	Value	Quarter
BANK OF AMERICA CORP /DE/	DOUBLED	135,783	277,497	+104.4%	$6.1M	2025-Q4
MORGAN STANLEY	ADD	154,545	209,668	+35.7%	$4.6M	2025-Q4
WELLS FARGO & COMPANY/MN	ADD	15,506	29,355	+89.3%	$643.8K	2025-Q4
TWO SIGMA INVESTMENTS, LP	ADD	164,639	297,963	+81.0%	$3.4M	2025-Q3
UBS Group AG	ADD	149,437	256,919	+71.9%	$3.0M	2025-Q3
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	ADD	128,048	162,167	+26.6%	$1.9M	2025-Q3
BANK OF AMERICA CORP /DE/	ADD	72,568	135,783	+87.1%	$1.6M	2025-Q3
VANGUARD GROUP INC	ADD	698,350	1,326,843	+90.0%	$24.9M	2025-Q2
TWO SIGMA INVESTMENTS, LP	NEW	—	164,639	—	$3.1M	2025-Q2
UBS Group AG	DOUBLED	19,951	149,437	+649.0%	$2.8M	2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	ADD	96,053	128,048	+33.3%	$2.4M	2025-Q2
BANK OF AMERICA CORP /DE/	DOUBLED	6,297	72,568	+1052.4%	$1.4M	2025-Q2
WELLS FARGO & COMPANY/MN	ADD	6,575	13,079	+98.9%	$245.0K	2025-Q2
MORGAN STANLEY	ADD	68,701	118,991	+73.2%	$2.3M	2025-Q1
UBS Group AG	TRIM	35,686	19,951	-44.1%	$383.3K	2025-Q1
CITADEL ADVISORS LLC	EXIT	206,350	0	-100.0%	$0.00	2025-Q1
NORGES BANK	EXIT	16,316	0	-100.0%	$0.00	2025-Q1
RENAISSANCE TECHNOLOGIES LLC	EXIT	41,900	0	-100.0%	$0.00	2025-Q1
CITADEL ADVISORS LLC	NEW	—	206,350	—	$5.3M	2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	NEW	—	96,582	—	$2.5M	2024-Q4
MORGAN STANLEY	NEW	—	68,701	—	$1.8M	2024-Q4
RENAISSANCE TECHNOLOGIES LLC	NEW	—	41,900	—	$1.1M	2024-Q4
UBS Group AG	NEW	—	35,686	—	$923.6K	2024-Q4
NORGES BANK	NEW	—	16,316	—	$422.3K	2024-Q4
WELLS FARGO & COMPANY/MN	NEW	—	6,434	—	$166.5K	2024-Q4

7 unique insiders with 16 transactions. Net insider value: -$1.7M ($0.00 bought, $1.7M sold).

Insider Transactions

Date	Insider	Title	Type	Shares	Price	Value
May 5, 2026	Chao Xingjuan	President and CEO	M	1,446	$0.00	$0.00
May 5, 2026	Chao Xingjuan	President and CEO	M	1,446	$4.70	$6.8K
May 5, 2026	Chao Xingjuan	President and CEO	SELL	14,000	$20.12	$281.7K
May 1, 2026	Woo Raymond	Chief Technology Officer	M	1,469	$2.24	$3.3K
May 1, 2026	Woo Raymond	Chief Technology Officer	SELL	1,469	$20.39	$30.0K
May 1, 2026	Woo Raymond	Chief Technology Officer	M	1,469	$0.00	$0.00
Apr 6, 2026	Chao Xingjuan	President and CEO	M	1,446	$4.70	$6.8K
Apr 6, 2026	Chao Xingjuan	President and CEO	M	1,446	$0.00	$0.00
Apr 6, 2026	Chao Xingjuan	President and CEO	SELL	14,000	$18.40	$257.6K
Apr 1, 2026	Manni Joseph S.	Chief Revenue Officer	A	51,227	$0.00	$0.00
Apr 1, 2026	Manni Joseph S.	Chief Revenue Officer	A	30,736	$0.00	$0.00
Apr 1, 2026	Chao Xingjuan	President and CEO	A	162,592	$0.00	$0.00
Apr 1, 2026	Chao Xingjuan	President and CEO	A	97,555	$0.00	$0.00
Apr 1, 2026	Blumberg Scott	Chief Financial Officer	A	51,227	$0.00	$0.00
Apr 1, 2026	Blumberg Scott	Chief Financial Officer	A	30,736	$0.00	$0.00
Apr 1, 2026	Woo Raymond	Chief Technology Officer	A	51,227	$0.00	$0.00
Apr 1, 2026	Foehr David	Senior VP, Finance and PAO	A	36,750	$0.00	$0.00
Apr 1, 2026	Woo Raymond	Chief Technology Officer	M	1,472	$0.00	$0.00
Apr 1, 2026	Woo Raymond	Chief Technology Officer	A	30,736	$0.00	$0.00
Apr 1, 2026	Woo Raymond	Chief Technology Officer	SELL	1,472	$18.58	$27.3K
Apr 1, 2026	Woo Raymond	Chief Technology Officer	M	1,472	$2.24	$3.3K
Apr 1, 2026	Foehr David	Senior VP, Finance and PAO	A	22,050	$0.00	$0.00
Mar 25, 2026	Chao Xingjuan	President and CEO	M	36,628	$0.00	$0.00
Mar 25, 2026	Chao Xingjuan	President and CEO	M	36,628	$2.24	$82.0K
Mar 3, 2026	ROBERTSON REBECCA B	Director	SELL	827	$17.80	$14.7K
Mar 3, 2026	Foehr David	Senior VP, Finance and PAO	M	3,403	$4.70	$16.0K
Mar 3, 2026	Foehr David	Senior VP, Finance and PAO	M	3,403	$0.00	$0.00
Mar 3, 2026	Chao Xingjuan	President and CEO	SELL	14,000	$17.45	$244.3K
Mar 3, 2026	Chao Xingjuan	President and CEO	M	1,446	$0.00	$0.00
Mar 2, 2026	Woo Raymond	Chief Technology Officer	M	1,472	$2.24	$3.3K
Mar 2, 2026	Woo Raymond	Chief Technology Officer	M	1,472	$0.00	$0.00
Feb 24, 2026	Foehr David	Senior VP, Finance and PAO	SELL	781	$19.98	$15.6K
Feb 23, 2026	Foehr David	Senior VP, Finance and PAO	SELL	569	$19.79	$11.3K
Feb 23, 2026	Blumberg Scott	Chief Financial Officer	SELL	808	$19.79	$16.0K
Feb 23, 2026	Chao Xingjuan	President and CEO	SELL	2,084	$19.79	$41.2K
Feb 23, 2026	Manni Joseph S.	Chief Revenue Officer	SELL	768	$19.79	$15.2K
Feb 23, 2026	Woo Raymond	Chief Technology Officer	SELL	705	$19.79	$14.0K
Feb 19, 2026	Parvizi Josef	Director	SELL	16,714	$20.27	$338.8K
Feb 4, 2026	Chao Xingjuan	President and CEO	SELL	14,000	$20.16	$282.2K
Feb 4, 2026	Chao Xingjuan	President and CEO	M	1,446	$4.70	$6.8K
Feb 4, 2026	Chao Xingjuan	President and CEO	M	1,446	$0.00	$0.00
Feb 3, 2026	Foehr David	Senior VP, Finance and PAO	SELL	3,403	$20.00	$68.1K
Feb 3, 2026	Foehr David	Senior VP, Finance and PAO	M	3,403	$0.00	$0.00
Feb 3, 2026	Foehr David	Senior VP, Finance and PAO	M	3,403	$4.70	$16.0K
Feb 2, 2026	Woo Raymond	Chief Technology Officer	M	1,472	$2.24	$3.3K
Feb 2, 2026	Woo Raymond	Chief Technology Officer	SELL	1,472	$20.57	$30.3K
Feb 2, 2026	Woo Raymond	Chief Technology Officer	M	1,472	$0.00	$0.00

12 SEC filing reports analyzed. Sentiment: 1 bullish, 4 bearish, 1 mixed, 6 neutral. Avg impact: 4.6/10.

MIXED PRESS-RELEASE 6/10

Ceribell reported Q1 2026 revenue of $26.5M (+29% YoY), beating the $26.1M consensus, and EPS of -$0

May 11, 2026

NEUTRAL CLUSTER 2/10

Insider cluster at Ceribill showing two sells by CEO and CTO totaling ~$312K, which is only 0.04% of

May 7, 2026

NEUTRAL PRESS-RELEASE 3/10

Ceribell issued a press release announcing the upcoming release of its Q1 2026 financial results, wi

Apr 20, 2026

NEUTRAL DEFA14A 3/10

Ceribell, Inc. filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. Th

Apr 20, 2026

BEARISH CLUSTER 5/10

Ceribell CEO Chao Xingjuan and CTO Woo Raymond sold a combined $285K in shares over the past week, w

Apr 8, 2026

NEUTRAL CLUSTER 3/10

Ceribell's CEO and CTO sold shares within the past week, with CEO Chao Xingjuan selling $244,300 wor

Mar 5, 2026

NEUTRAL CLUSTER 2/10

Ceribell's Chief Technology Officer, Raymond Woo, exercised stock options for 1,472 shares at $2.24

Mar 4, 2026

NEUTRAL INST-CLUSTER 5/10

Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — initiated ne

Feb 28, 2026

BEARISH CLUSTER 6/10

Six Ceribell executives, including the CEO, CFO, CTO, and other C-suite leaders, sold shares in a co

Feb 26, 2026

BEARISH CLUSTER 6/10

Six Ceribell executives sold shares in a concentrated 7-day window, including CEO Chao Xingjuan and

Feb 25, 2026

BEARISH CLUSTER 6/10

Six corporate insiders at Ceribell, Inc. (CBLL) sold shares in a concentrated 7-day window, includin

Feb 25, 2026

BULLISH 8-K, 8-K 8/10

Ceribell reported strong financial results for Q4 and full year 2025, with revenue growth of 34% and

Feb 24, 2026

∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (93% buy). Based on 14 analysts: 7 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$26.86 mean target +48.5% upside Strong Buy (1.13)

$24.00 Low $32.00 High

Metric	Value
Current Price	$18.09
Target Low	$24.00
Target Mean	$26.86
Target Median	$26.00
Target High	$32.00
# Analysts	7
Recommendation	Strong Buy (1.13)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-06-30	$-0.46	$-0.50	$-0.36	-20.6%	-17.6%	0↑ 3↓	$0.0B	28.7%	4
Next Q 2026-09-30	$-0.37	$-0.38	$-0.34	-0.1%	-5.6%	1↑ 2↓	$0.0B	27.7%	4
Current FY 2026-12-31	$-1.68	$-1.74	$-1.55	-15.2%	-15.5%	0↑ 3↓	$0.1B	28.0%	4
Next FY 2027-12-31	$-1.10	$-1.30	$-0.91	34.7%	-9.2%	1↑ 3↓	$0.1B	28.0%	5

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$-0.458
7d ago	$-0.390	-0.069
30d ago	$-0.390	-0.069
60d ago	$-0.390	-0.069
90d ago	$-0.368	-0.090

2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
May 12, 2026	Canaccord Genuity	MAINTAIN	Buy	Buy
Jan 28, 2026	BTIG	REITERATE	Buy	Buy
Dec 17, 2025	Canaccord Genuity	MAINTAIN	Buy	Buy
Dec 15, 2025	BTIG	REITERATE	Buy	Buy

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Buy %
May 1, 2026	7	6	1	93%
Apr 1, 2026	7	6	1	93%
Mar 1, 2026	7	6	1	93%
Feb 1, 2026	7	6	1	93%
Jan 1, 2026	7	6	1	93%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 20, 2026

other

Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference

<p>SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transform

May 11, 2026

earnings

Ceribell Reports First Quarter 2026 Financial Results

<p align="left">SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused

May 11, 2026

earnings_calendar

CBLL Q1 2026 Earnings Scheduled — 2026-05-11

Apr 20, 2026

earnings

Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026

<p>SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transfo

Feb 24, 2026

earnings_calendar

CBLL Q4 2025 Earnings After Market Close — 2026-02-24